# Giordano Caponigro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giordano-caponigro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,256 |
| Field | Melanoma and MAPK Pathways |
| h-index | 36 |
| i10-index | 46 |
| Last Known Institution | Novartis (Switzerland) |
| OpenAlex ID | https://openalex.org/A5025118565 |
| Works | 304 |

## Researcher papers

- [The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity](https://scholariq.org/papers/the-cancer-cell-line-encyclopedia-enables-predictive-modelling-of-anticancer/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Protein Tyrosine Phosphatases](https://scholariq.org/topics/protein-tyrosine-phosphatases/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Synthesis and biological activity](https://scholariq.org/topics/synthesis-and-biological-activity/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)

## Researcher university

- [Novartis (Switzerland)](https://scholariq.org/institutions/novartis-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.